The International AIDS Society (IAS) is currently inviting civil society organizations and HIV prevention service providers to nominate Youth Champions for HIV prevention among key populations in Eastern Europe Eastern Europe to develop a nuanced understanding of current primary prevention practices and models that effectively address the ...

The purpose of this information note is to support civil society and community groups to design and include community systems strengthening interventions and community-based monitoring activities in funding requests during the 2017-2019 Global Fund funding cycle. This information will be of interest to community groups, ...

Planning for this year’s High Level Political Forum is starting to pick up. In this document you will find some basic information to ensure you are up to speed in the upcoming processes and deadlines. More information will be shared periodically. When: July 10-19 Where: UN Headquarters, ...

Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 313 of the “Global Fund Observer.” The newsletter features articles on various topics, including Zambia’s prioritization of front-line rural health workers in TB/HIV and malaria funding requests; differences between ...

Hepatitis B and C virus infections are associated with a considerable burden of disease in Europe. ECDC undertook a survey to assess needs and priorities prior to developing guidance on testing and screening for hepatitis B and C in the EU/EEA, and to update the existing ...

Introduction Pursuant to a license negotiated by the Medicines Patent Pool (MPP) with ViiV Healthcare (ViiV), an important new antiretroviral medicine, dolutegravir (DTG), will soon be available via generic competition in all low- and lower-middle-income countries, and a significant number of upper-middle-income countries as well. DTG ...

To support countries to integrate human rights principles in their HIV prevention, testing and treatment programmes, UNAIDS and the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) jointly launched two mutually supportive technical documents on 29 May. The UNAIDS guidance document Fast-Track and human ...

In May 2016, the World Health Assembly endorsed the Global Health Sector Strategy (GHSS) on viral hepatitis 2016–2021. The GHSS calls for the elimination of viral hepatitis as a public health threat by 2030 (reducing new infections by 90% and mortality by 65%). This WHO Global ...

Georgia is currently facing a problem of a high incidence of tuberculosis (TB) and relatively low treatment success rates. Many patients are not followed up properly which contributes to high levels of multidrug-resistant TB: 12 % of new patients are resistant to first line drugs. ...

The Medicines Patent Pool (MPP) released a short film, in which MPP’s stakeholders from industry, government, civil society and patient groups discuss the foundation’s innovative business model, achievements and future plans to increase access to HIV, hepatitis C and TB treatment within the context of ...

Launch of the Report of the High-Level Working Group on the Health and Human Rights of Women, Children and Adolescents At a high-level side event, the Report of the High-Level Working Group on the Health and Human Rights of Women, Children and Adolescents was officially handed ...

An Activist's Protocol Review Toolkit is designed to facilitate community participation in the development and review of clinical trials protocols. The three tools contained in the toolkit will help Community Advisory Boards (CABs) think through different aspects of trial design and implementation, organize feedback for the research ...

Several anecdotal reports of mouth ulcers have recently been reported in people switching to generic abacavir in the UK. This should highlight awareness of the potential of likely-rare new side effects, even when both formulations have been approved as bioequivalent. These are likely to be very uncommon reactions, ...

Civil society must remain vigilant to ensure that UN Member States take concrete action toward meeting targets to end AIDS by 2030 With this in mind, MSMGF has compiled video excerpts from the 2016 High Level Meeting on Ending AIDS (HLM) so we may continue to hold States ...

Some of the world’s largest funders of medical research and international non-governmental organizations today agreed on new standards that will require all clinical trials they fund or support to be registered and the results disclosed publicly. In a joint statement, the Indian Council of Medical Research, ...

This independent report, commissioned by WHO and written by Sir Liam Donaldson, reflects on the trends, achievements and challenges in global health over the past decade during which Dr Margaret Chan has been Director-General of WHO. It discusses the role of WHO in dealing with ...

As chronic hepatitis C virus (HCV) drug development approaches the end-game following the launch of the first pan-genotypic regimen Epclusa (; Gilead), recent and upcoming advances in chronic hepatitis B virus (HBV) treatment emerged as an important focus of the International Liver Conference (ILC) 2017, ...

Almost half of all deaths globally are now recorded with a cause, new data from WHO show, highlighting improvements countries have made on collecting vital statistics and monitoring progress towards the Sustainable Development Goals (SDGs). Several countries have made significant strides towards strengthening the data they ...